| 08/14/2026 4:15 PM | Tharimmune (1861657) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/14/2026 8:30 AM | Tharimmune (1861657) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 07/17/2026 7:30 AM | Tharimmune (1861657) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/15/2026 6:11 PM | Tharimmune (1861657) Issuer Nangalia Rishi (2142129) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 07/15/2026 6:02 PM | Tharimmune (1861657) Issuer Galvin Sean (1619516) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 07/15/2026 6:06 PM | Tharimmune (1861657) Issuer Carter Pamela L (1396958) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 07/08/2026 5:14 PM | ARK Investment Management LLC (1697748) Filed by Tharimmune (1861657) Subject | Form SCHEDULE 13G/A | |
| 06/25/2026 6:58 AM | Tharimmune (1861657) Filer | Form DEF 14A | |
| 06/16/2026 7:30 AM | Tharimmune (1861657) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/27/2026 5:35 PM | Tharimmune (1861657) Issuer Stetz Gary S. (1532793) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/13/2026 8:00 AM | Tharimmune (1861657) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
Get the Latest News and Ratings for THAR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Tharimmune and its competitors with MarketBeat's FREE daily newsletter.
|
| 05/11/2026 5:03 PM | Tharimmune (1861657) Subject LCV FUND VIII, L.P. (1858209) Filed by | Form SCHEDULE 13G/A | |
| 04/15/2026 11:35 AM | Tharimmune (1861657) Filer | Form D Notice of Exempt Offering of Securities | |
| 04/15/2026 11:31 AM | Tharimmune (1861657) Filer | Form D Notice of Exempt Offering of Securities | |
| 03/31/2026 8:00 AM | Tharimmune (1861657) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/31/2026 7:15 AM | Tharimmune (1861657) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/03/2026 7:15 AM | Tharimmune (1861657) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/18/2026 7:45 AM | Tharimmune (1861657) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/11/2026 4:18 PM | Sommers Jill E. (1737622) Reporting Tharimmune (1861657) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 02/11/2026 4:20 PM | Radkowski Angela Dominy (2105789) Reporting Tharimmune (1861657) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 02/11/2026 4:16 PM | Tharimmune (1861657) Issuer Wiley William Thomas Jr. (2099981) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 02/11/2026 4:14 PM | Asbury Jacob (2101731) Reporting Tharimmune (1861657) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 02/06/2026 7:20 AM | Tharimmune (1861657) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/03/2026 10:39 AM | ARK Investment Management LLC (1697748) Filed by Tharimmune (1861657) Subject | Form SCHEDULE 13G | |
| 02/02/2026 8:26 PM | LCV FUND VIII, L.P. (1858209) Filed by Tharimmune (1861657) Subject | Form SCHEDULE 13G | |
| 02/02/2026 7:20 AM | Tharimmune (1861657) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/26/2026 8:51 PM | Tharimmune (1861657) Filer | Form DEFA14A | |
| 01/26/2026 7:50 AM | Tharimmune (1861657) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/22/2026 3:12 PM | Tharimmune (1861657) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/21/2026 11:30 AM | BlackRock, Inc. (2012383) Filed by Tharimmune (1861657) Subject | Form SCHEDULE 13G/A | |
| 01/20/2026 9:52 AM | Tharimmune (1861657) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/20/2026 8:05 AM | Tharimmune (1861657) Filer | Form 424B5 | |
| 01/19/2026 11:15 PM | Tharimmune (1861657) Filer | Form EFFECT | |
| 01/15/2026 3:10 PM | Tharimmune (1861657) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/09/2026 3:34 PM | Tharimmune (1861657) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 01/06/2026 3:37 PM | Tharimmune (1861657) Filer | Form PRER14A | |
| 01/06/2026 3:37 PM | Tharimmune (1861657) Filer | Form PRER14A | |
| 01/06/2026 3:37 PM | Tharimmune (1861657) Filer | Form PRER14A | |
| 12/17/2025 8:28 PM | Tharimmune (1861657) Filer | Form 424B3 | |
| 12/16/2025 11:15 PM | Tharimmune (1861657) Filer | Form EFFECT | |
| 12/16/2025 3:20 PM | Tharimmune (1861657) Filer | Form PRE 14A | |
Elon gets it. Do you? (Ad) Moderna's stock jumped nearly 200% in a single day after a successful Phase 3 trial for its cancer drug, and Merck added $43 billion to its market cap on the same news.
Porter & Co. says AI-driven drug discovery and automated labs are cutting development timelines by up to 80% and lifting early clinical success rates to 90%, fueling what they call biotech's Ignition Point. Stream the free Ignition Point broadcast for the full biotech breakdown. |
| 12/12/2025 7:45 AM | Tharimmune (1861657) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/05/2025 3:52 PM | Tharimmune (1861657) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 12/05/2025 3:13 PM | Tharimmune (1861657) Filer | Form 424B3 | |
| 11/27/2025 11:15 PM | Tharimmune (1861657) Filer | Form EFFECT | |
| 11/14/2025 1:18 PM | Tharimmune (1861657) Issuer Toomey Mark Christopher (2095900) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 11/14/2025 1:20 PM | Tharimmune (1861657) Issuer Wendland Mark Paul (2096174) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 11/10/2025 4:31 PM | Tharimmune (1861657) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/06/2025 8:46 PM | Tharimmune (1861657) Filer | Form 424B5 | |
| 11/06/2025 8:50 PM | Tharimmune (1861657) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/06/2025 4:15 PM | Tharimmune (1861657) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/05/2025 7:57 PM | Appajosyula Sireesh (1901565) Reporting Tharimmune (1861657) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/05/2025 7:57 PM | Kahler Thomas Clay (2082864) Reporting Tharimmune (1861657) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/05/2025 7:57 PM | Gravitas Capital LP (1840140) Reporting Tharimmune (1861657) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/05/2025 7:57 PM | Stetz Gary S. (1532793) Reporting Tharimmune (1861657) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/05/2025 7:57 PM | Rickel Nancy Davis (2083262) Reporting Tharimmune (1861657) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/05/2025 7:57 PM | LoPriore Vincent S (1633927) Reporting Tharimmune (1861657) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/05/2025 7:57 PM | Liddy James Gordon (2082917) Reporting Tharimmune (1861657) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/05/2025 7:57 PM | Parikh Sanam (2046430) Reporting Tharimmune (1861657) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/05/2025 8:15 AM | Tharimmune (1861657) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/03/2025 8:27 AM | Tharimmune (1861657) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/17/2025 5:40 PM | BlackRock, Inc. (2012383) Filed by Tharimmune (1861657) Subject | Form SCHEDULE 13G | |
| 10/17/2025 3:37 PM | Tharimmune (1861657) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 10/17/2025 3:16 PM | Tharimmune (1861657) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 10/10/2025 3:22 PM | Tharimmune (1861657) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/06/2025 7:24 AM | Tharimmune (1861657) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/06/2025 7:26 AM | Tharimmune (1861657) Filer | Form 424B3 | |
| 10/06/2025 7:28 AM | Tharimmune (1861657) Filer | Form 424B3 | |